Moderna
Biotechnology Cambridge, Massachusetts Private Corporation

Our Company

Moderna is a clinical stage pioneer of messenger RNA Therapeutics™, an entirely new in vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. This breakthrough platform addresses currently undruggable targets and offers a superior alternative to existing drug modalities for a wide range of diseases and conditions. Moderna is developing and plans to commercialize its innovative mRNA drugs through its own ventures and its strategic relationships with established pharmaceutical and biotech companies. Its current ventures are: Onkaido, focused on oncology, Valera, focused on infectious diseases, Elpidera, focused on rare diseases, and Caperna, focused on personalized cancer vaccines. Cambridge-based Moderna is privately held and currently has strategic agreements with AstraZeneca, Alexion Pharmaceuticals and Merck.

Skills We're Looking For

Biotechnology Pharmaceutical Manufacturing Biology Molecular Biology Biochemistry Pharmacology Knowledge of Cell Culture Knowledge of RNA Isolation Chemistry Project Management Technical Skill Rigor In vitro Enzymology Documentation Human Immunology Nucleic Acid Subject Matter Expert engineering Current Good Manufacturing Practice (CGMP) Bachelor of Science (BS) Safety Evaluating the Reliability and Validity of Biological Research Studies Laboratory Methods and Techniques Leadership Product Evaluation Techniques Animal Studies Bioassay Enzyme-Linked Immunosorbent Assay Western Blot IntraCellular Cytokine Staining Flow Cytometry RT-PCR